Opportunities in the Chinese pharmaceutical market must be part of any company’s strategy — whether as a client, a supplier, a competitor, or a partner. Opportunities exist for innovative treatments, orphan drugs, and technology partnerships.

Program

China Pharmaceutcal Market, Dr Bruno LERAILLEZ

Summary/Discussion/Questions

Bruno Leraillez, CEO & founder of Innoledge International Ltd

Based in Hong Kong since 1994. Graduate of ENVA and Paris University of Medicine.

Kishor Kumar Shrestha. Manager Innoledge International

Pharmacist graduated from China Pharmaceutical University (Nanjing).